Advances in Dermatology and Allergology
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2025
vol. 42
 
Share:
Share:
Original paper

Effects of antioxidant-anti-inflammatory therapy on skin rejuvenation and repair. The clinical case series study

Dorota Sobolewska-Sztychny
1, 2, 3
,
Magdalena Ciążyńska
1
,
Joanna Narbutt
1, 2
,
Natalia Bień
1, 2
,
Aleksandra Lesiak
1, 2, 3

  1. Dermoklinika Medical Center, Lodz, Poland
  2. Department of Dermatology, Paediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland
  3. Laboratory of Autoinflammatory, Genetic and Rare Skin Disorders, Department of Dermatology, Paediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland
Adv Dermatol Allergol 2025; XLII (4): 387-392
Online publish date: 2025/07/15
Article file
- Effects (1).pdf  [0.24 MB]
Get citation
 
 

Introduction

Skin aging is an inevitable biological process characterized by cellular changes and diminished regenerative capabilities over time [1, 2]. Endogenous factors such as chronological aging and hormonal imbalances, alongside exogenous influences from the environment, collectively contribute to this process [3]. Various theories, including genetic mechanisms, Hayflick, mitochondrial dysfunction, membrane alterations, and protein degradation, attempt to elucidate the mechanisms underlying skin aging. The genetic theory posits that DNA harbours the information responsible for aging processes. As cells undergo multiple aging stages, the decline in healthy cells and the accumulation of intracellular mutations, exacerbated by free radicals, lead to irreversible cellular damage [4].

Oxidative stress, induced by environmental pollutants, UV radiation, and other factors, significantly contributes to skin aging and pigmentation [5]. Studies suggest that enhancing antioxidant defences and activating the Nrf2 pathway may mitigate oxidative damage and ameliorate skin aging and pigmentation [6]. Notable antioxidant molecules such as glutathione, α-tocopherol, ascorbic acid, and various enzymes play crucial roles in combating oxidative stress [7]. Ferulic acid, a phenolic compound abundant in plant-based foods, has gained attention for its potent antioxidant and anti-inflammatory properties. Its inclusion in cosmetic formulations, particularly as a stabilizer for vitamins C and E, highlights its protective effects on key skin components, including keratinocytes, fibroblasts, collagen, and elastin [8].

This study evaluates the efficacy of a novel combined therapy for skin rejuvenation, leveraging the antioxidant and peptide-promoting properties of ferulic acid and TGF-β2. This advanced chemical peel not only stimulates anti-aging effects but also combats signs of exogenous aging. The treatment involves a two-step process of chemical peeling and microinjection, shielding skin cells from DNA damage caused by external and internal factors while neutralizing cytotoxic radicals. In vitro studies have confirmed the formulation’s potent antioxidant capabilities [8].

The focus of our investigation was to assess the effectiveness of the proposed therapy in improving skin conditions in individuals experiencing aging. We analysed its impact based on factors such as concentration, solution pH, and application duration [911].

Material and methods

A total of 20 healthy female subjects meeting the predefined inclusion and exclusion criteria were recruited.

Inclusion criteria

Female participants with Fitzpatrick skin types II–IV exhibiting initial signs of aging, mature skin characteristics, superficial discoloration, post-inflammatory pigmentation, and enlarged sebaceous glands.

Age range:

  • 25–50 years.

  • General good health status.

  • Provision of signed informed consent.

Exclusion criteria

  • Pregnancy or breastfeeding.

  • Known hypersensitivity to any component of the investigated product.

  • Fever, active inflammation, or active viral/bacterial infections.

  • Current oral administration of isotretinoin or other retinoids.

  • Autoimmune disorders.

  • Ongoing inflammatory skin conditions.

  • Chronic internal organ dysfunction or dermatological conditions.

  • Irritated, damaged, tanned, or sunburned skin, or open wounds.

  • Predisposition to keloid formation.

The participants, all Caucasian women aged 25 to 50 years (mean age: 36.73 ±6.43 years), were categorized according to the Fitzpatrick classification into skin phototypes II (n = 6), III (n = 12), and IV (n = 2).

Each participant underwent three treatments at 2-week intervals, resulting in a 6-week treatment period. During the intervention, participants applied an antioxidative serum with vitamin C and ferulic acid twice daily after facial cleansing and used a photoprotective cream with SPF 50+.

Study visits and assessments

Four study visits were conducted, during which the following assessments were performed:

  1. Photographic documentation using Photofinder.

  2. Videodermoscopic examination of facial skin at 20× magnification using Photofinder.

  3. Measurement of skin pH, transepidermal water loss (TEWL), hydration levels, and sebaceous gland activity using equipment from Courage+Khazaka electronic GmbH.

At the fourth visit, treatment efficacy was evaluated based on improvements in redness, skin tone, pigmentation, dryness, wrinkles, skin texture, and sebaceous gland activity.

Procedures

The treatment protocol involved the application of two products. First, an antioxidant solution containing ferulic acid, peptides, and TGF-β2 was applied to the facial skin as a peel. Then, an antioxidative cocktail with peptides and ferulic acid was administered during mesotherapy. Following the procedure, patients were instructed to apply antioxidative serum with vitamin C and ferulic acid and sunscreen SPF30 with vitamin C, ferulic acid and vitamin E twice daily as part of their daily skincare routine.

The treatment area was adequately ventilated, and patients’ eyes were shielded during the peeling process to prevent irritation. Initially, makeup removal was performed, followed by the application of peel with ferulic acid, peptides and TGF-β2 (two layers for 5 min each). Ten minutes after the initiation of the first peel layer, neutralization was carried out. Following this, one ampoule of antioxidative cocktail with peptides and ferulic acid was evenly distributed over the face, and the product was administered via micro-needle mesotherapy (with puncture depth set at 0.5 mm). Upon complete absorption of the antioxidative cocktail with peptides and ferulic acid, sunscreen SPF30 with vitamin C, ferulic acid and vitamin E was applied to the treated skin.

Adverse events

Throughout the study, no severe adverse events were reported by none of the patients.

Statistical analysis

The collected data underwent analysis utilizing the Statistica 13 software package. The Friedman ANOVA test for dependent groups and the Wilcoxon pairwise order test were employed to assess the statistical significance of the observed results.

Results

A total of 20 female participants, aged between 25 and 50 years, successfully completed the study. Following the therapy, noticeable improvements were observed in all patients. Physical examinations revealed reductions in erythema, wrinkles, skin flaccidity, and the number of sebaceous glands. Photographic documentation further confirmed reductions in hyperpigmentation and enhancements in skin tone (Figures 14).

Figure 1

Photo of the patient, reduction of erythema, before (A) and after (B) the therapy

/f/fulltexts/PDIA/56520/PDIA-42-4-56520-g001_min.jpg
Figure 2

Photo of the patient, reduction of hyperpigmentation, before (A) and after (B) the therapy.

/f/fulltexts/PDIA/56520/PDIA-42-4-56520-g002_min.jpg
Figure 3

Photo of the patient, reduction in flaccidity and number of sebaceous glands, before (A) and after (B) the therapy

/f/fulltexts/PDIA/56520/PDIA-42-4-56520-g003_min.jpg
Figure 4

Photo of the patient, lifting effect, reduction of wrinkles and improvement of skin tone, before (A) and after (B) the therapy

/f/fulltexts/PDIA/56520/PDIA-42-4-56520-g004_min.jpg

Our investigation showed a significant reduction in pH levels. The mean buccal pH decreased from 6.18 ±0.41 before treatment to 5.48 ±0.49 after 6 weeks (p < 0.05) (Table 1). Similarly, transepidermal water loss (TEWL) measurements demonstrated a significant improvement; the mean buccal TEWL decreased from 12.91 ±0.63 g/h/m² before treatment to 9.46 ±0.66 g/h/m² after 6 weeks (p < 0.05) (Table 1).

Table 1

The difference in pH, TEWL and sebum levels in individual visits

PatientBefore treatmentAfter 2 weeksAfter 4 weeksAfter 6 weeks
pH levelTEWL levelSebum levelpH levelTEWL levelSebum levelpH levelTEWL levelSebum levelpH levelTEWL levelSebum level
16.2713.5292.136.0912.1584.735.7011.0282.835.6310.1279.96
26.0213.8291.125.5612.4384.245.5211.3285.265.0210.4080.85
36.5213.9888.246.4512.6281.365.8111.4878.945.8210.6478.62
46.4812.5268.326.4611.0061.256.2010,0260.635.989.0156.26
56.2512.4284.626.0111.0677.745.649.9276.455.628.9473.62
65.9812.3283.945.7910.9573.625.539.8274.645.288.2470.66
75.5611.7484.625.3010.0775.255.189.2478.124.758.3475.23
85.9812.0190.275.6510.7283.395.559.5180.975.288.9484.76
96.1512.9869.235.9011.5965.045.6010.461.335.459.4658.66
106.4512.6310.,346.4111.3295.465.8110.1393.045.759.1291.62
116.1713.2698.235.8711.8491.355.6410.7689.465.479.8287.87
126.1312.35103.235.8110.9496.355.589.8594.255.529.1291.55
136.9812.3269.236.8010.8362.355.619.8259.936.288.8857.25
147.0313.23121.456.9311.83110.186.4810.73102.526.459.8095.23
156.0113.5887.235.7812.1780.355.4711.0879.525.1110.1381.25
166.0713.2565.225.7611.8358.355.6210.7561.235.379.8053.62
175.8512.53103.235.6111.1293.145.3010.0393.935.159.0793.34
185.9213.5262.355.5412.1162.735.4111.0253.055.1210.1150.22
196.6212.6361.776.2611.1962.626.0910.1359.976.119.1749.60
205.2513.59124.135.0212.69113.924.9011.2599.014.4210.1297.45
Mean6.1812.9187.555.9511.5280.675.6310.4178.255.489.4675.38
Standard deviation0.410.6317.640.470.6915.710.340.6414.410.490.6615.55
P-value0.0326*0.0008*0.3642

Although changes in sebum levels were observed, they did not reach statistical significance (p > 0.05). The mean sebum level on the cheek decreased from 87.55 ±17.64 μg/cm² before treatment to 75.38 ±15.55 μg/cm² after 6 weeks (Table 1).

Discussion

The present study demonstrated that this novel therapy was well tolerated by all patients, with no reported cases of irritation. Clinical examinations revealed notable improvements, including reductions in discoloration, erythema, and superficial wrinkles, as well as enhancements in skin firmness and overall tone [12, 13]. Our research employed an innovative treatment method – a combination that, to our knowledge, has not been previously reported in the literature. For example, similar research by Sołdacka et al. evaluated the efficacy of chemical peels in reducing uneven skin tone, pigmentation, dehydration, dryness, textural irregularities, and sebaceous gland activity. The results achieved with a 4% retinol solution containing novel TGF-β activators and antioxidants were quite similar to ours in terms of overall skin rejuvenation [6].

Our findings corroborate previous research on the therapeutic efficacy of ferulic acid in combating oxidative stress-related skin pathologies, such as aging. Ferulic acid, often used in combination with other active ingredients, has shown promise in various formulations. Studies have reported its synergistic effects with oral vitamins C and E, azelaic acid, mandelic acid, phytic acid, and 4 N-butyl resorcinol. Notably, combination therapies incorporating ferulic acid have demonstrated significant reductions in pigmentation, as evidenced by Mazurek and Pierzchała [14]. Consistent with these findings, our study also observed reductions in hyperpigmentation, as confirmed by photographic documentation.

Moreover, the mechanisms underlying ferulic acid’s therapeutic effects have been elucidated in the literature. It is reported to reduce reactive oxygen species levels in fibroblasts, thereby protecting cellular DNA and mitigating UV-induced cell cycle arrest and DNA damage [15]. Additionally, the inclusion of TGF-β2 in the peel formulation activates pathways associated with type I collagen production and epidermal lipid synthesis – mechanisms similar to those induced by retinoids. These actions contribute to improvements in skin integrity and protection, as reported by Sołdacka et al. [6] and observed in our study.

The multifaceted nature of this therapy was further evidenced by significant improvements in skin hydration, pH normalization, and sebum regulation. The reduction in wrinkles is particularly noteworthy, given that an acidic skin pH has been associated with decreased wrinkle formation, as reported by Jung et al. [16]. Furthermore, the reduction in transepidermal water loss (TEWL) observed in our study is crucial for addressing cutaneous aging, as highlighted by Wilhelm et al. These findings suggest that the therapy effectively alleviates skin dryness, thereby supporting its anti-aging properties.

Despite the promising results, our study has several limitations. The relatively short duration and treatment period may have limited the full extent of the observed effects. Additionally, the absence of a control group and the short assessment period (limited to 2 weeks post-treatment) warrant further investigation over longer durations. Nonetheless, the satisfactory outcomes observed in this study underscore the potential benefits of this therapy in skin rejuvenation and repair. Its high tolerability and minimal side effects support its year-round use across various skin types [17, 18].

Ethical approval

The study protocol was approved by the Independent Bioethics Committee for Scientific Research at the Medical University of Lodz, Poland (Approval number: RNN/109/23/KE). Before enrolment, written informed consent was obtained from all participants.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Resich-Kozieł L, Niemyska K. Rodzaje oraz przyczyny starzenia siê skóry. Kosmetol Estet 2020; 9: 17-22.

2 

Zegarska B, Woźniak M. Przyczyny wewnątrzpochodnego starzenia siê skóry. Gerontol Pol 2006; 14: 153-9.

3 

Dêbowska R, Bazela K, Eris I. Fotoliaza i endonukleaza w ochronie skóry przed fotostarzeniem. Dermatol Estet 2008; 10: 90-6.

4 

Osika G, Wesołowska A. Niechirurgiczne metody opóźniające procesy starzenia się skóry. Farm Pol 2020; 2: 110-7.

5 

Bickers DR, Athar M. Novel approaches to chemoprevention of skin cancer. J Dermatol 2000; 27: 691-5.

6 

Sołdacka D, Podgórska M, Barańska-Rybak W. Unique retinol therapy with antioxidant and anti-inflammaging complex for naturally reborn skIn: the clinical case series study. Dermatol Ther 2023; 2023: 588525.

7 

Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 2006; 126: 2565-75.

8 

Üstündas M, Yener Hb, Helvaci SS. Parameters affecting lycopene extraction from tomato powder and its antioxidant activity. Anadolu Univ J Sci Technol A Appl Sci Engineering 2019; 19: 454-67.

9 

Chen J, Liu Y, Zhao Z, Qiu J. Oxidative stress in the skIn: impact and related protection. Int J Cosmet Sci 2021; 43: 495-509.

10 

Kanagalakshmi A, Rajendra Prasad N. Ferulic acid prevents ultraviolet-B radiation induced oxidative DNA damage in human dermal fibroblasts. Int J Nutr Pharmacol Neurol Dis 2014; 4: 203-13.

11 

Hahn HJ, Kim KB, Bae S, et al. Pretreatment of ferulic acid protects human dermal fibroblasts against ultraviolet A irradiation. Ann Dermatol 2016; 28: 740-8.

12 

Funasaka Y, Komoto M, Ichihashi M. Depigmenting effect of alpha-tocopheryl ferulate on normal human melanocytes. Pigment Cell Res 2000; 13: 170-4.

13 

Kim J, Kim J, Lee YI, et al. Effect of a topical antioxidant serum containing vitamin C, vitamin E, and ferulic acid after Q-switched 1064-nm Nd:YAG laser for treatment of environment-induced skin pigmentation. J Cosmet Dermatol 2020; 19: 2576-82.

14 

Mazurek K, Pierzchała E. Comparison of efficacy of products containing azelaic acid in melasma treatment. J Cosmet Dermatol 2016; 15: 269-82.

15 

Shu P, Mo J, Li Z, et al. Ferulic acid in synergy with retinol alleviates oxidative injury of HaCaT cells during UVB-induced photoaging. Aging (Albany NY) 2024; 16: 7153-73.

16 

Jung YC, Kim EJ, Cho JC, et al. Effect of skin pH for wrinkle formation on Asian: Korean, Vietnamese and Singaporean. J Eur Acad Dermatol Venereol 2013; 27: 328-32.

17 

Kottner J, Lichterfeld A, Blume-Peytavi U. Transepidermal water loss in young and aged healthy humans: a systematic review and meta-analysis. Arch Dermatol Res 2013; 305: 315-23.

18 

Akdeniz M, Gabriel S, Lichterfeld-Kottner A, et al. Transepidermal water loss in healthy adults: a systematic review and meta-analysis update. Br J Dermatol 2018; 179: 1049-55.

Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.